Antimicrobial resistance (AMR) cannot be defeated by
focusing on human health and agriculture alone. The
environment must become an integral part of the global
response, with countries moving beyond political commitments
to concrete action on pollution prevention, environmental
surveillance and sustainable investment.
That is the
central message from Aitziber Echeverria, AMR Coordinator,
Chemicals and Health Branch at the United Nations
Environment Programme (UNEP), who argues that environmental
action is no longer an optional component of the fight
against AMR but a prerequisite for its success.
“AMR
is often discussed as a public health and agriculture
challenge — which of course it is, and a major one — but
it is an environmental issue too,” Echeverria
said.
Her warning comes as global efforts increasingly
recognise that AMR is not confined to hospitals, farms or
healthcare facilities. Drug-resistant microorganisms,
antimicrobial residues and resistance genes can enter and
circulate through the environment, making pollution control
and environmental management essential to containing the
threat.
“The environment plays a key role in the
emergence, transmission and spread of AMR, as per the UNEP
report Bracing for Superbugs. The environment and AMR cannot
be treated separately. That is the One Health concept,”
she said while speaking at the 6th Annual Global Media Forum
on AMR ahead of World AMR Awareness Week (WAAW 2026:
November 18-24).
From recognition to
implementation
Advertisement – scroll to continue reading
For Echeverria, the global
conversation has reached a decisive turning point: the
environmental dimensions of AMR are increasingly
acknowledged, but recognition must now translate into
implementation.
“We are moving now from recognising
the environmental dimensions of AMR to systematically
addressing them. We now need implementation,” she
said.
The 2024 UN General Assembly Political
Declaration on AMR reinforced the need for coordinated
action across sectors. Echeverria stressed that
environmental considerations must be embedded in this
response rather than treated as an afterthought. “As stated
in the 2024 UN General Assembly Political Declaration, to
tackle AMR we need to combine multi-sectoral and
sector-specific actions, and the environment needs to be
considered at the core, as part of the solution.”
A
further milestone came in December 2025, when Member States
adopted a resolution on the environmental dimensions of AMR
at the United Nations Environment Assembly, the UN’s highest
decision-making body on the environment.
Prevention
must start upstream
The most urgent priority,
according to Echeverria, is to prevent antimicrobial
pollution before it creates conditions for resistance to
emerge and spread. “We need to reduce the release of
antimicrobial residues, drug-resistant microorganisms and
genes into the environment before they become a challenge.
This means tackling pollution at its source – upstream,”
said Aitziber Echeverria.
She identified four priority
economic sectors where targeted interventions could
significantly reduce environmental contributions to
AMR.
The first is pharmaceutical and chemical
manufacturing, where industrial discharges containing
antimicrobial residues must be reduced.
The second is
agriculture and food systems, encompassing terrestrial and
aquatic animal production as well as crop production. More
sustainable production practices, she argued, can help limit
environmental contamination.
The third is healthcare
systems, where responsible antimicrobial stewardship can
prevent unnecessary releases.
The fourth is municipal
systems, where untreated or inadequately treated waste and
wastewater can contribute to the emergence and spread of
resistance.
Together, these sectors illustrate why AMR
cannot be addressed through isolated interventions.
Pollution generated in one sector can create consequences
across human, animal and environmental
health.
Environmental surveillance as an
early-warning system
Alongside prevention, Echeverria
called for stronger environmental knowledge, monitoring and
information-sharing to help countries identify emerging
threats and direct interventions where they are most needed.
“Countries need stronger environmental monitoring and
surveillance systems because environmental data can provide
an early warning of AMR hotspots and sources, which can help
identify where and which interventions are
needed.”
The establishment of the Independent Panel on
Evidence for Action against AMR (IPEA), expected to take
place in Abuja at the upcoming Fifth Global High-Level
Ministerial Conference on AMR, is another important
development in strengthening the evidence base for
action.
Breaking down institutional silos
But
stronger evidence and ambitious commitments will not be
enough unless countries address a fundamental governance
problem: environmental authorities are often excluded from
national AMR decision-making. Echeverria warned against
fragmented policies and regulations that separate
environmental priorities from national AMR strategies.
“There should be no fragmentation in policies and regulation
— at global but most importantly at national level —
with AMR incorporated into the environmental agendas and the
environment at the core of AMR plans, policies and
interventions.”
In addition, she emphasised that
environmental institutions must have a formal role in
national AMR governance mechanisms from the beginning,
rather than being consulted only after strategies have been
developed. For Echeverria, this is central to making One
Health meaningful in practice.
This should also
translate into concrete environmental objectives and
indicators in national AMR action plans, backed by adequate
funding.
Investment is essential, not
optional
“Environmental interventions require
funding to prevent AMR: strengthening wastewater treatment
infrastructure, establishing or improving systems for safe
disposal of antimicrobials, supporting laboratory and
surveillance capacity, and generating environmental AMR data
will help countries make evidence-based decisions and
measure progress,” said Echeverria.
Such
investments, she argued, should also be connected to broader
environmental programmes, including pollution reduction,
improved water quality, sound chemical management, better
waste management and sustainable production and
consumption.
The benefits would extend well beyond AMR
prevention. “Addressing environmental drivers of AMR can
deliver multiple benefits, including progress on public
health, biodiversity protection, water security, and it
contributes to tackling the triple planetary crisis of
climate change, nature loss and pollution,” she
said.
Global commitments must deliver local
results
The urgency of translating commitments into
implementation was echoed by Dr Jean-Pierre Nyemazi,
Director a.i. of the WHO AMR Department and Director of the
Quadripartite Joint Secretariat on AMR.
“AMR is one of
the most urgent global health threats and development
challenges. It threatens our ability to treat infections,
protect animal and plant health, and produce safe food, and
also has an impact on the environment,” he said. The scale
of the threat is already staggering. Nyemazi noted that
bacterial AMR alone was associated with more than 4.7
million deaths in 2021. “These are not just statistics.
Behind these numbers are patients, families, farmers and
communities.”
Dr Nyemazi cautioned that the problem is
driven by interconnected failures, including antimicrobial
misuse and overuse, inadequate infection prevention, poor
water and sanitation, and environmental contamination. “AMR
does not recognize borders or sectors.”
While the 2024
UN Political Declaration established targets for 2030,
including reducing deaths associated with bacterial AMR by
10 per cent and ensuring that at least 60 per cent of
countries have funded national action plans, implementation
remains a major challenge. “However, let’s be honest. The
gap between commitments and pledges versus implementation
remains wide,” Dr Nyemazi said.
The updated Global
Action Plan on AMR for 2026–2036 and the forthcoming Fifth
Global High-Level Ministerial Conference in Abuja, Nigeria,
from 6–8 December 2026, are expected to provide further
momentum.
But, as Dr Nyemazi emphasised, “global
pledges matter only when they deliver results in
communities”.
One Health must reach the community
level
Dr Kefas Samson, Senior Technical Officer and
Lead of Multisectoral Coordination at WHO’s AMR Department,
highlighted the importance of translating global strategies
into interventions that reflect national needs and local
realities.
He stressed that countries must assess
their needs, prioritise and cost interventions, and ensure
that implementation is aligned with available resources.
Primary healthcare and community-based services also have a
critical role in driving sustainable behavioural change,
strengthening infection prevention, enabling early diagnosis
and ensuring timely and appropriate treatment.
Dr
Samson identified inadequate financing, weak surveillance,
limited diagnostic capacity, gaps in access to
quality-assured antimicrobials and shortages of healthcare
workers among the continuing barriers to progress. “The
Global Action Plan on AMR 2026-2036 places greater emphasis
on coordinated One Health action — and that includes human
health, animal health, agriculture, and
environment.”
Countries cannot afford to treat
environmental protection as a secondary consideration in the
AMR response, stressed Aitziber Echeverria. “We need
stronger collaboration across sectors to reduce
environmental pollution from antimicrobials and resistant
microorganisms and genes. This is what UNEP is supporting,
because all these are must-haves. Environmental action on
AMR is not an optional addition to the response. It is a
prerequisite for success in addressing AMR with One Health
approach. If we do not address the environmental dimensions
of AMR, we risk undermining efforts in human and animal
health.”
“On the contrary, if we invest — and
sometimes invest is repurposing ongoing investment and
incentive schemes — so, if we invest in prevention,
pollution reduction and integrated One Health approaches, we
can curb the emergence and spread of AMR while advancing
sustainable development and protecting future generations,”
she said.
Shobha Shukla – CNS (Citizen News
Service)
(Shobha Shukla is a feminist, health
and development justice advocate, and an award-winning
founding Managing Editor and Executive Director of CNS
(Citizen News Service). She serves as Chairperson of Global
AMR Media Alliance (GAMA), Host and Coordinator of SHE &
Rights (Sexual Health with Equity & Rights), President
of Asia Pacific Media Alliance for Health, Gender and
Development Justice (APCAT Media), and founder leader of
DJOP (Development Justice for Older Persons) initiative. She
is the author of 2026 book “Justice Unbound: Feminist Voices
on Gender Equality, Health Rights, and Inclusive Futures”
and was also the Lead Discussant for SDG-3 at United Nations
inter-governmental High Level Political Forum 2025. GAMA ,
led by her, received the AMR One Health Emerging Leaders and
Outstanding Talents Award at UN High Level Ministerial
Conference on AMR 2024. Follow her on X @shobha1shukla or
read her writings here www.bit.ly/ShobhaShukla)

